Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: new + drug + pfizer  Related to the article below (Last Update: 8/5/2008)

Pfizer setting up key unit in Mission Bay
Bizjournals.com, NC -
New York-based Pfizer is counting on the BBC as a long-term source of new drugs and technologies to deepen its portfolio, and Goodman's job is to look ...

Boston Globe
Drug stocks gain; Elan climbs on upgrade
MarketWatch - 44 minutes ago
Several large-cap pharmaceuticals gained ground, with shares of blue chips Pfizer Inc. (PFE: Ireland-based Elan (UK:ELA: news, chart, profile) has seen its ...
Elan Becomes a Bad News Buy Motley Fool
all 220 news articles »  ELN - BIIB - PINK:ELNCF
New York-Based Sanders Law Firm Files Five Product Liability ...
PR Web (press release), WA -
... that he has filed five separate product liability lawsuits against Pfizer, Inc., manufacturer of the hugely popular Chantix smoking cessation drug. ...
Squire Sanders Continues New York Expansion MarketWatch
all 7 news articles »  PFE
Pfizer spent nearly $3.1 million lobbying in 2Q
Forbes, NY -
Pfizer (nyse: PFE - news - people ) also lobbied on bills to allow generic drug companies to sell cheaper copies of biotech drugs. ...
Drug industry trade group spent $5M lobbying in 2Q Forbes
all 4 news articles »  PFE
Treating AIDS Patients
Accra Daily Mail, Ghana -
It takes an average of $1.3 billion and between 10 and 15 years to develop a new drug and bring it to market. By allowing a drugmaker to remain the sole ...
LOWER TARIFFS TO FIGHT AIDS New York Post
The right way to fight AIDS Los Angeles Times
Discurso de Dr. Luis-Soto Ramirez en la Sesion de Apertura de AIDS ... Enkidu Magazine
all 578 news articles »  BDX - ABT
Get a Deep Insight Into the Commercial and Pipeline Insight ...
MarketWatch -
As has been successful for Pfizer, televised direct-to-consumer (DTC) drug advertising campaigns will continue to be an important marketing tool for new ...
Changes at the helm of Actavis Group
MarketWatch -
The new Chief Executive Officer is Sigurdur Oli Olafsson, former Deputy CEO. Sigurdur Oli Olafsson joined Actavis in 2003, after working for Pfizer UK from ...LON:INV - OTC:CMTX
Behavioral Therapy to Enable Women with Urge Incontinence to ...
Annals of Internal Medicine -
Additional support, including provision of study drugs and funding, was contributed by Pfizer. Potential Financial Conflicts of Interest: Consultancies: KL ...
Epilepsy Drug May Help Alcoholics Recover From Dependence, Small ...
Science Daily (press release) - Aug 4, 2008
The study was funded by the National Institutes of Health, and the study medication was provided by Parke-Davis (now Pfizer), which markets gabapentin as ...
Roche tipped to be world's top drugmaker by 2014
Reuters - Aug 4, 2008
VX: Quote, Profile, Research, Stock Buzz) is set to become the world's biggest drugmaker by sales in 2014, as current market leader Pfizer Inc (PFE. ...OTC:RHHBY - SWF:RO - SWF:HUE
Source: Google News

-
M Angell - Jurimetrics, 2004 - HeinOnline
... not important new drugs, but minor variations of drugs already on the market--called
"me-too" drugs. For example, the top-selling drug in the world, Pfizer's ...

The druggable genome -
AL Hopkins, CR Groom - Nat Rev Drug Discov, 2002 - jade.botany.utoronto.ca
... NCE, new chemical entity ... The limited number of small-molecule drug targets suggests
that to ... Informatics, Structure and Design Department, Pfizer Global Research ...

The price of innovation: new estimates of drug development costs -
JA DiMasi, RW Hansen, HG Grabowski - Journal of Health Economics, 2003 - Elsevier
... These data were used to estimate the average pre-tax cost of new drug development. ...
The chart also shows the number of US new drug approvals by year. ...

The making of a disease: female sexual dysfunction -
R Moynihan - BMJ, 2003 - pubmedcentral.nih.gov
... a new category of human illness at meetings heavily sponsored by companies racing
to develop new drugs. The most recent gathering, featured Pfizer as chief ...

Social Relations and Innovation in the Medical Profession: The Epidemiology of a New Drug -
H Menzel, E Katz - Public Opinion Quarterly, 1955 - JSTOR
... Medical Profession: The Epidemiology of a New Drug* By HERBERT ... and ELIHU KATZ A study
of drug adoptions by ... Pfizer & Co., Inc., manufacturers of chemicals and ...

… computational approaches to estimate solubility and permeability in drug discovery and development … -
CA Lipinski, F Lombardo, BW Dominy, PJ Feeney - Advanced Drug Delivery Reviews, 2001 - Elsevier
... is now the major, rich source of drug discovery leads ... At the Pfizer Groton site,
we have retrospectively examined the ... further jump in 1992 to a new stable MWT ...

IGF-1: Old Growth Factor Shines as New Drug Target -
K Garber - jnci, 2005 - jnci.oxfordjournals.org
... launched a phase I trial of a new monoclonal antibody against cancer. The target:
the insulin-like growth factor 1 (IGF-1) receptor. Pfizer's drug was the ...

… Ischemic Optic Neuropathy Developing Soon After Use of Sildenafil (Viagra): A Report of Seven New -
HD Pomeranz, AR Bhavsar - Journal of Neuro-Ophthalmology, 2005 - jneuro-ophthalmology.com
... Sildenafil citrate (Viagra; Pfizer Pharmaceuticals, New York, NY ... the most frequently
reported adverse events associated with use of this drug. ...

VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES -
RL Walsky, RS Obach - Drug Metabolism and Disposition, 2004 - ASPET
... Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Pfizer, Inc., Groton,
Connecticut. The measurement of the effect of new chemical entities on human ...

STATISTICS: Bayes Offers a'New'Way to Make Sense of Numbers -
D Malakoff - Science, 1999 - sciencemag.org
... The Pfizer study, in contrast, should allow researchers to analyze the accumulating
data and ... In a trial comparing a new drug to no treatment, for instance, a ...

Source: Google Scholar

EU wants new warnings on Pfizer anti-smoking drug

Last Updated: 2007-12-14 10:16:56 -0400 (Reuters Health)

 

 

LONDON - The European Medicines Agency said on Friday that new warnings for doctors and patients were needed to increase awareness of cases of suicidal thoughts linked to Pfizer Inc's new smoking cessation pill.

Pfizer has been asked to submit changes to the marketing information for the product -- sold as Champix in Europe and Chantix in the United States -- before Dec. 19.

The move follows similar action by the U.S. Food and Drug Administration, which issued a warning last month about Chantix, amid reports of suicidal thoughts and behaviour, and at least one death potentially linked to the medication.

Pfizer said there was no scientific evidence establishing a causal relationship between its medicine and these reported events, adding it was working closely with the European watchdog to review case histories.

The world's biggest pharmaceutical company reported revenue of $241 million for Chantix in the third quarter of 2007, which, though significant, does not rank it among its major drugs.

Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Childhood asthma persists in most children

Last Updated: 2007-12-14 12:03:26 -0400 (Reuters Health)

NEW YORK (Reuters Health) - More than half the children who develop asthma before 6 years of age continue to have asthma at age 12 years, according to results of a Canadian study.

"Our study showed that 50 percent of the young children diagnosed with asthma before age 6 continued to have asthma at age 12," Dr. Teresa To from The Hospital for Sick Children in Toronto, Ontario, told Reuters Health. "This finding does not support the common belief that children 'outgrow' asthma."

The investigators used provincial population-based data to follow young children with asthma from birth until early adolescence. The study included all children born in Ontario during 1994 and diagnosed with asthma before the age of 6 years.

Of the 34,216 asthmatic children, roughly 54 percent experienced a second asthma episode requiring hospitalization or a physician visit within the next year, the investigators report, and nearly three quarters did so within 3 years of diagnosis.

Persistent asthma at age 12 was more common among children diagnosed with asthma between 2 and 5 years of age than among those diagnosed before the age of 2 years, the report indicates, and persistent asthma was more common among boys than among girls.

Asthma persistence was also more likely in children living in cities than in children living in rural areas, but low socioeconomic status was not a risk factor.

Children with asthma diagnosed prior to age 6 years often had allergies, like hay fever and dermatitis, the researchers note, and those with allergic conditions were more likely than those without to have persistent asthma by age 12 years.

The risk of having persistent asthma was 3-fold higher among children with at least one asthma hospitalization and 2.6-fold higher among children with at least four physician visits.

SOURCE: Archives of Pediatrics & Adolescent Medicine, December 2007.

Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.